Insights
Mike Martin assumed his new role as President and CEO of ISPE and the ISPE Foundation in January.
Katie LeChase
ISPE
Katie is a public relations and communications strategist with 15+ years of experience working hand-in-hand with organizations to develop and implement overarching communications strategies that engage audiences and move people to action. Her key areas of focus have been in healthcare, life sciences, and B2B tech-focused communications and public relations.
Katie has driven strategic plans and initiatives for more than a dozen healthcare-focused organizations, including publicly traded life science companies, medical centers and hospitals, health networks, health information exchanges, health tech startups, healthcare-focused nonprofits, and more. Institutions she has supported include the University of Rochester Medical Center, the Breast Cancer Research Foundation's The Pink Agenda, IQVIA and TraceLink. Her approach is research-oriented, metrics-driven, and audience-centric.
Katie has driven strategic plans and initiatives for more than a dozen healthcare-focused organizations, including publicly traded life science companies, medical centers and hospitals, health networks, health information exchanges, health tech startups, healthcare-focused nonprofits, and more. Institutions she has supported include the University of Rochester Medical Center, the Breast Cancer Research Foundation's The Pink Agenda, IQVIA and TraceLink. Her approach is research-oriented, metrics-driven, and audience-centric.
Related Articles
InTouch
Governments around the world have made international commitments to reduce their environmental impact and protect nature. Policy frameworks have been established to facilitate and drive progress against agreed-upon targets. These directly impact end-to-end activities for the biopharmaceutical, pharmaceutical, and medical device sectors, including research and development, manufacturing,...
InTouch
ISPE recently announced ISPE AI®, an initiative aimed at aiding the pharmaceutical industry in realizing the potential of artificial intelligence (AI). The initiative will include a multifaceted approach to...
iSpeak Blog
The proliferation of digital tools available in the pharmaceutical industry, including artificial intelligence (AI) and machine learning (ML), is revolutionizing drug discovery and manufacturing processes.
iSpeak Blog
In the rapidly evolving pharmaceutical landscape, artificial intelligence (AI) has been hailed as having the potential to revolutionize everything from drug discovery to pharmaceutical manufacturing. As the industry seeks to further explore and invest in potential opportunities for improvement and growth with AI, pursuing a thoughtful and informed approach to AI strategy planning becomes...